awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37968255-373F3BFF-3A0A-4C87-9459-878CC3227763
Q37968255-373F3BFF-3A0A-4C87-9459-878CC3227763
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37968255-373F3BFF-3A0A-4C87-9459-878CC3227763
Recent advances in the application of antibodies as therapeutics.
P2860
Q37968255-373F3BFF-3A0A-4C87-9459-878CC3227763
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37968255-373F3BFF-3A0A-4C87-9459-878CC3227763
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3c014b4e3717e307331503d842b4ac0d3f15b02
P2860
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.